logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Dihydropyridine Calcium Channel Blocker class drugs

    FiltersReset Filters
    8 results

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • cleviprex

      (clevipidine)
      Chiesi USA, Inc.
      Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.

    • felodipine

      (Felodipine Extended-release Tablets)
      Yiling Pharmaceutical Inc.
      Usage: Felodipine Extended-release Tablets are indicated for treating hypertension to lower blood pressure, reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It should be part of a comprehensive cardiovascular risk management strategy, often requiring combination therapy with other antihypertensive agents.

    • katerzia

      (Amlodipine)
      Azurity Pharmaceuticals, Inc.
      Usage: KATERZIA is indicated for treating hypertension in adults and children (6 years and older) to reduce blood pressure and cardiovascular risks. It is also used for chronic stable angina, vasospastic angina, and to lower hospitalization risks in patients with confirmed coronary artery disease.

    • norliqva

      (amlodipine)
      CMP Pharma, Inc.
      Usage: NORLIQVA® is indicated for treating hypertension in adults and children ages 6 and older, reducing cardiovascular event risk. It also treats chronic stable angina, vasospastic angina, and helps patients with angiographically documented coronary artery disease to lower hospitalization and revascularization risks. It can be used alone or with other agents.

    • norvasc

      (amlodipine besylate)
      Viatris Specialty LLC
      Usage: NORVASC® is indicated for the treatment of hypertension, chronic stable angina, vasospastic angina, and to reduce hospitalization risk in patients with documented coronary artery disease. It may be used alone or in combination with other antihypertensive or antianginal agents to manage these conditions effectively.

    • nymalize

      (nimodipine)
      Azurity Pharmaceuticals, Inc.
      Usage: NYMALIZE is indicated for improving neurological outcomes in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms, by reducing the incidence and severity of ischemic deficits, irrespective of the patients' neurological condition post-ictus (Hunt and Hess Grades I-V).

    • tribenzor

      (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide)
      Cosette Pharmaceuticals, Inc.
      Usage: Tribenzor is indicated for treating hypertension, either alone or with other antihypertensive agents, to lower blood pressure. This reduces the risk of cardiovascular events, such as strokes and myocardial infarctions. It is not intended for initial hypertension therapy and should be part of comprehensive cardiovascular risk management.